Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EBIT Growth

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   EBIT Growth(%) 13.34-79.18-

What is the latest EBIT Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EBIT Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 13.34 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202513.34
Mar2024-79.18
Mar2023-

How is EBIT Growth of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EBIT Growth % Change
Mar2025 13.34
Positive
Mar2024 -79.18
0
Mar2023 0 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EBIT Growth ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,876.2 Cr 22.8% 50.9% 44.5% Stock Analytics
SAGILITY ₹19,216.8 Cr -0.1% -1.7% -4.4% Stock Analytics
PRIME FOCUS ₹18,134.9 Cr -4.4% -24.1% 139.4% Stock Analytics
SYNGENE INTERNATIONAL ₹17,797.8 Cr -2.2% 5.1% -26.8% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹16,195.2 Cr -1.6% 3.7% 2.5% Stock Analytics
INDEGENE ₹12,532.9 Cr 2.2% 4.5% -14.6% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

22.8%

50.9%

44.5%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses